`Tel: 571-272-7822
`Entered: March 6, 2017
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`COALITION FOR AFFORDABLE DRUGS VIII, LLC,
`Petitioner,
`
`v.
`
`THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA,
`Patent Owner.
`_____________
`
`
`
`Case IPR2015-01835 (Patent 8,618,135 B2)
`Case IPR2015-01836 (Patent 7,932,268 B2)1
`____________
`
`
`
`
`Before GRACE KARAFFA OBERMANN and MICHAEL P. TIERNEY,
`Vice Chief Administrative Patent Judges, LORA M.GREEN, Administrative
`Patent Judge.
`
`GREEN, Administrative Patent Judge.
`
`
`
`ORDER
`Granting Patent Owner’s Motion to Seal
`37 C.F.R. §§ 42.14 and 42.54
`
`
`
`1 This order addresses issues that are the same in the identified cases. We
`exercise our discretion to issue one order to be filed in each case. The
`parties are authorized to use this style heading when filing a single paper in
`the listed proceedings, provided that such heading includes a footnote
`attesting that “the word-for-word identical paper is filed in each proceeding
`identified in the heading.”
`
`
`
`IPR2015-01835 (Patent 8,618,135 B2)
`IPR2015-01836 (Patent 7,932,268 B2)
`
`Patent Owner filed a Motion to Seal in both of the above proceedings.
`
`Paper 19 in both IPR2015-01835 and IPR2016-01836. Pursuant to 37
`C.F.R. §§ 42.14 and 42.54, Patent Owner seeks to seal portions of Exhibits
`2057, 2081, and 2082 in both proceedings. Id. at 1. Patent Owner certifies
`that to the best of “the undersigned counsel’s knowledge, the information
`sought to be sealed by this motion has not been published or otherwise made
`public.” Id. at 3. Petitioner did not file an opposition to the Motion to Seal.
`In addition, the parties also seek entry of the default protective order. Paper
`17 in both IPR2015-01835 and IPR2016-01836.
`The standard for granting a motion to seal is “for good cause.” 37
`C.F.R. § 42.54. The party moving to seal bears the burden of proof of
`showing entitlement to the requested relief, and establishing that information
`sought to be sealed is confidential information. 37 C.F.R. § 42.20(c). Only
`“confidential information” is protected from disclosure. 35 U.S.C.
`§ 316(a)(7); see Office Patent Trial Practice Guide, 77 Fed. Reg. 48756,
`48760 (Aug. 14, 2012).
`Under 35 U.S.C. § 326(a)(1) and 37 C.F.R. § 42.14, the default rule is
`that all papers filed in an inter partes review are open and available for
`access by the public; a party, however, may file a concurrent motion to seal,
`and the information at issue is sealed pending the outcome of the motion.
`There is, however, a strong public policy in favor of making information
`filed in an inter partes review open to the public, especially because these
`proceedings determine the patentability of claims in issued patents and,
`therefore, affect the rights of the public. See Garmin Int’l v. Cuozzo Speed
`Techs., LLC, Case IPR2012-00001, slip op. at 1-3 (PTAB Mar. 14, 2013)
`(Paper 34) (discussing the standards applied to motions to seal).
`
`
`
`2
`
`
`
`IPR2015-01835 (Patent 8,618,135 B2)
`IPR2015-01836 (Patent 7,932,268 B2)
`
`
`Patent Owner contends that “Exhibit 2082 contains confidential
`patient information,” as it “references specific clinical data for patients in
`connection with studies conducted by or through the University of
`Pennsylvania.” Paper 19, 1. Patent Owner contends that the “public’s
`interest in accessing this information for the purposes of the patentability of
`the challenged claims in this proceeding is outweighed by the prejudicial
`effect that such disclosure would have on Patent Owner, who is required to
`maintain the privacy of patients treated by or through the University of
`Pennsylvania.” Id. at 1‒2.
`We agree that Exhibit 2082 appears, on its face, to contain
`confidential patient information. We are persuaded that Patent Owner shows
`good cause for redacting sensitive information from that Exhibit.
`Accordingly, we grant Patent Owner’s Motion to Seal as to Exhibit 2082.
`
`Patent Owner contends that “Exhibits 2057 and 2081 contain
`confidential business information of Patent Owner (and of Aegerion, Inc.,
`the exclusive licensee of the patent under review in this proceeding) relating
`to certain clinical trials conducted on lomitapide by Patent Owner or by
`Bristol-Myers Squibb Company (“BMS”).” Paper 19, 2.
`We agree that Exhibits 2057 and 2081 appear, on their face, to contain
`confidential business information. We are persuaded that Patent Owner
`shows good cause for redacting the sensitive information from those
`exhibits. Accordingly, we grant Patent Owner’s Motion to Seal Confidential
`Exhibits 2057 and 2081.
`
`We would like to note that Petitioner filed a redacted and unredacted
`copy of its Reply (Papers 30 and 29 in IPR2015-01835, and Papers 32 and
`31 in IPR2015-01836). Petitioner also filed Exhibit 1057 in IPR2015-01835
`
`
`
`3
`
`
`
`IPR2015-01835 (Patent 8,618,135 B2)
`IPR2015-01836 (Patent 7,932,268 B2)
`
`and Exhibit 1053 in IPR2015-01836 as Board and parties only, and filed
`both a redacted and unredacted copy of Exhibit 1049 in IPR2015-01835 and
`Exhibit 1045 in IPR2015-01836. Neither Petitioner nor Patent Owner,
`however, has filed a corresponding motion to seal the Reply or those
`exhibits.
`
`37 C.F.R. § 42.14 requires that a “party intending a document or thing
`to be sealed [to] file a motion to seal concurrent with the filing of the
`document or thing to be sealed.” As no motion to seal accompanied either
`the Reply in the proceedings, or the aforementioned exhibits, within 30 days
`of this Order, either Petitioner or Patent Owner should file a motion to seal
`the Reply and the exhibits. If no such motion is received, the Reply in its
`entirety, as well as the above mentioned exhibits, will be made available to
`the public.
`Accordingly, it is:
`ORDERED that the parties Motion for Entry of the default protective
`order into the proceedings is granted;
`FURTHER ORDERED that Patent Owner’s Motion to Seal Exhibits
`2057, 2081, and 2082 is granted;
`FURTHER ORDERED that either Patent Owner or Petitioner should
`file a motion to seal Petitioner’s Reply in both proceedings within 30 days of
`the date of this Order;
`FURTHER ORDERED that either Patent Owner or Petitioner should
`file a motion to seal Exhibits 1049 and 1057 in IPR2015-01835, and
`Exhibits 1045 and 1049 in IPR2015-01836; and
`
`
`
`4
`
`
`
`IPR2015-01835 (Patent 8,618,135 B2)
`IPR2015-01836 (Patent 7,932,268 B2)
`
`
`FURTHER ORDERED that if no such motion is filed within 30 days
`of this order, Petitioner’s Reply and Exhibits 1049 and 1057 in IPR2015-
`01835, and Exhibits 1045 and 1049 in IPR2015-01836 will be made public.
`
`
`
`5
`
`
`
`IPR2015-01835 (Patent 8,618,135 B2)
`IPR2015-01836 (Patent 7,932,268 B2)
`
`For PETITIONER:
`
`Gregory Gonsalves
`gonsalves@gonsalveslawfirm.com
`
`Christopher Casieri
`MCNEELY, HARE & WAR, LLP
`chris@miplaw.com
`
`
`For PATENT OWNER:
`
`William G. James
`Cynthia Lambert Hardman
`GOODWIN PROCTER LLP
`wjames@goodwinprocter.com
`chardman@goodwinprocter.com
`
`
`
`
`6
`
`